NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Wednesday, July 11th. Stockholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 annualized dividend and a dividend yield of 3.02%. The ex-dividend date is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its quarterly earnings results on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.09. The pharmacy operator earned $45.69 billion during the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a return on equity of 17.45% and a net margin of 3.59%. CVS Health's quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.17 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

CVS Health updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

18 equities research analysts have issued 1-year price targets for CVS Health's stock. Their predictions range from $68.00 to $99.00. On average, they anticipate CVS Health's share price to reach $86.3125 in the next year. This suggests a possible upside of 30.5% from the stock's current price. View Analyst Ratings for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

CVS Health saw a increase in short interest in the month of June. As of June 29th, there was short interest totalling 43,844,028 shares, an increase of 0.4% from the June 15th total of 43,662,443 shares. Based on an average daily trading volume, of 9,965,640 shares, the days-to-cover ratio is presently 4.4 days. Approximately 4.3% of the shares of the stock are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Headlines about CVS stock have been trending somewhat negative on Thursday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CVS Health earned a coverage optimism score of -0.06 on Accern's scale. They also gave media headlines about the pharmacy operator an impact score of 47.74 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Bank of Montreal Can (0.40%), Swedbank (0.20%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.13%), DnB Asset Management AS (0.12%) and Retirement Systems of Alabama (0.12%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., Atwood & Palmer Inc., DnB Asset Management AS, Swedbank, Hartford Investment Management Co., Gateway Investment Advisers LLC and Welch & Forbes LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was purchased by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Howard Capital Management Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Factory Mutual Insurance Co., Adams Asset Advisors LLC, TNB Financial, Addenda Capital Inc. and Farmers Trust Co.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $66.14.

CVS Health has a market capitalization of $69.07 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]